Abstract
HLA-A2 antigens are divided into four subtypes, designated A2.1 to A2.4, by the use of cytolytic T lymphocytes (CTL). The A2.4 subtype consists of a functionally heterogeneous group of variants that are not recognized by A2.1-, A2.2-, or A2.3-specific CTL lines while it is indistinguishable from A2.1 by isoelectric focusing. The structure of an A2.4 variant expressed on donor KNE has been established by comparative peptide mapping with A2.1 and radiochemical sequencing. It was found to differ from A2.1 by a single amino acid change of Cys to Tyr at position 99. This position is only moderately polymorphic and has not previously been found to vary in any other HLA or H-2 variants. The nature of the change is compatible with its generation by one-point mutation from A2.1. The only other previously characterized A2.4 variant, CLA, differs from A2.1 by a single amino acid replacement at position 9. Both residues 9 and 99 are located in homologous positions within the α1 and α2 domains, respectively. The results shown contribute to the molecular interpretation of the heterogeneity of CTL recognition within the HLA-A2.4 group of antigens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CTL:
-
cytotoxic T lymphocytes
- HPLC:
-
high performance liquid chromatography
References
Aparicio, P., Vega, M. A., and López de Castro, J. A.: One allogeneic cytolytic T lymphocyte clone distinguished three different HLAB27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition. J. Immunol. 135: 3074–3081, 1985
Aparicio, P., Rojo, S., Jaraquemada, D., and López de Castro, J. A.: Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones. J. Immunol. 139: 837–841, 1987
Biddison, W. E., Krangel, M. S., Strominger, J. L., Ward, F. E., Shearer, G. M., and Shaw, S.: Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules. Hum. Immunol. 3: 225–232, 1980
Biddison, W. E., Shearer, G. M., and Shaw, S.: Influenza virus-specific cytotoxic T cells are restricted by multiple HLA-A3-related self antigens: evidence for recognition of distinct self structures in conjunction with different foreign antigens. J. Immunol. 127: 2231–2235, 1981
Biddison, W. E., Kostyu, D. D., Strominger, J. L., and Krangel, M. S.: Delineation of immunologically and biochemically distinct HLA-A2 antigens. . J. Immunol. 129: 730–734, 1982
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennet, W. S., Strominger, J. L., and Wiley, D. C.: Structural identification of the foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512–518, 1987
Brenner, M. B., McLean, J., Yang, S. Y., van der Peel, J. J., Pious, D., and Strominger, J. L.: Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule. J. Immunol. 135: 384–390, 1985
Breur-Vriesendorp, B. S., Dekker, A. J., Breuning, M. H., and Ivanyi, P.: Subtypes of antigen HLA-B27 (B27W and B27K) defined by cytotoxic T lymphocytes: identification of a third subtype (B27C) prevalent in Oriental populations. In M. Ziff and S. B. Cohen (eds.): Advances in Inflammation Research. Vol. 9: Espondylarthropathies, pp. 55–65, Raven Press, New York, 1985
Cowan, E. P., Jordan, B. R., and Coligan, J. E.: Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte defined HLA-A3 subtypes: the E1 subtype. J. Immunol. 135: 2835–2841, 1985
Ezquerra, A., Doménech, N., van der Poel, J. J., Strominger, J. L., Vega, M. A., and Lopez de Castro, J. A.: Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes. J. Immunol. 137: 1642–1649, 1986
Gaston, J. S. H., Rickinson, A. B., and Epstein, M. A.: Epstein-Barr virus specific cytotoxic T lymphocytes as probes of HLA polymorphism: heterogeneity of T cell restricting determinants associated with the serologically defined HLA-A2 antigen. J. Exp. Med. 158: 280–293, 1983
Gotch, F. M., Kelly, C., Ellis, S. A., Wallace, L., Rickinson, A., van der Poel, J. J., Crumpton, M. J., and McMichael, A. J.: Characterization of the HLA-A2.2 subtype: T cell evidence for heterogeneity. Immunogenetics 21: 11–23, 1985
Goulmy, E., van der Poel, J., Giphart, M., and van Rood, J. J.: Analysis of the functional epitopes on different HLA-A2 molecules. Immunogenetics 20: 13–21, 1984
Güssow, D., Rein, R. S., Meijer, L, de Hoog, W., Seemann, G. H. A., Hochstenbach, F. M., and Ploegh, H. L.: Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: evolutionary aspects. Immunogenetics 25: 313–322, 1987
Holmes, N., Ennis, P., Wan, A. M., Dennoy, D. W., and Parham, P.: Multiple genetic mechanisms have contributed to the generation of the HLA-A2/A28 family of class I MHC molecules. J. Immunol. 139: 936–941, 1987
Krangel, M. S., Taketani, S., Biddison, W. E., Strong, D. M., and Strominger, J. L.: Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: variants M7 and DR1. Biochemistry 21: 6313–6321, 1982
Krangel, M. S., Biddison, W. E., and Strominger, J. L.: Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes. II. Variant DK1: evidence for a discrete CTL recognition region. J. Immunol. 130: 1856–1862, 1983a
Krangel, M. S., Taketani, S., Pious, D., and Strominger, J. L.: HLA-A2 mutants immunoselected in vitro. Definition of residues contributing to an HLA-A2-specific serological determinant. J. Exp. Med. 157: 324–336, 1983b
Layet, C., Kahn-Perles, B., Pontarotti, P., Ferrier, P., Sire, J., and Lemonnier, F.: Creation of an HLA-A2/Aw69 alloantigenic determinant on an HLA-A3 molecule by site directed mutagenesis. J. Immunol. 138: 2197–2201, 1987
López de Castro, J. A., Orr, H. T., Robb, R. J., Kostyk, T. G., Mann, D. L., and Strominger, J. L.: Complete amino acid sequence of papain-solubilized human histocompatibility antigen, HLA-137. I. Isolation and amino acid composition of fragments and of tryptic and chymotryptic peptides. Biochemistry 18: 5704–5711, 1979
Mattson, D. H., Handy, D. E., Bradley, D. A., Coligan, J. E., Cowan, E. P., and Biddison, W. E.: DNA sequences of the genes that encode the CTL-defined HLA-A2 variants M7 and DK1. Immunogenetics 26: 190–192, 1987
Nathenson, S. G., Geliebter, J., Pfaffenbach, G. M., and Zeff, R. A.: Murine major histocompatibility complex class I mutants: molecular analysis and structure-function implications. Annu. Rev. Immunol. 4: 471–502, 1986
Parham, P. and Bodmer, W. F.: Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 276: 397–399, 1978
Parham, P., Humphreys, R. E., Turner, M. J., and Strominger, J. L.: Microheterogeneity of HL-A antigen preparations is due to variable sialic acid content. Proc. Natl. Acad. Sci. U.S.A. 71: 3998–4001, 1974
Rojo, S., Aparicio, P., Choo, S. Y., Hansen, J. A., and López de Castro, J. A.: Structural analysis of an HLA-1327 population variant, B27f: multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-1327. J. Immunol. 139: 831–836, 1987
Salter, R. D., Clayberger, C., Lomen, C. E., Krensky, A. M., and Parham, P.: In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule. J. Exp. Med., in press, 1987
Seemann, G. H. A., Rein, R. S., Brown, C. S., and Ploegh, H. L.: Gene conversion-like mechanisms may generate polymorphism in human class I genes. EMBO J. 5: 547–552, 1986
Sherman, L. A.: Recognition of conformational determinants on H-2 by cytolytic T lymphocytes. Nature 297: 511–513, 1982
Spits, H., Breuning, M., Ivanyi, P., Russo, C., and de Vries, J. E.: In vitro-isolated human cytotoxic T-lymphocyte clones detect variations in serologically defined HLA antigens. Immunogenetics 16: 503–512, 1982
Toubert, A., Gomard, G., Grumet, F. C., Amor, B., Muller, J. Y., and Levy, J. P.: Identification of several functional subgroups of HLAB27 by restriction of the activity of antiviral T killer lymphocytes. Immunogenetics 20: 513–525, 1984
van der Poel, J. J., Mölders, H., Thompson, A., and Ploegh, H. L.: Definition of four HLA-A2 subtypes by CML typing and biochemical analysis. Immunogenetics 17: 609–621, 1983
van der Poel, J. J., Pool, J., Goulmy, E., Giphart, M. J., and van Rood, J. J.: Recognition of distinct epitopes on the HLA-A2 antigen by cytotoxic T lymphocytes. Hum. Immunol. 16: 247–258, 1986
Van Schravendijk, M. R., Biddison, W. E., Berger, A. E., and Coligan, J. E.: Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1. J. Immunol. 134: 410–416, 1985
Vega, M. A., Bragado, R., Ezquerra, A., and López de Castro, J. A.: Variability and conformation of HLA class I antigens: a predictive approach to the spatial arrangement of polymorphic regions. Biochemistry 23: 823–831, 1984
Vega, M. A., Ezquerra, A., Rojo, S., Aparicio, P., Bragado, R., and López de Castro, J. A.: Structural analysis of an HLA-1327 functional variant: identification of residues that contribute to the speci ficity of recognition by cytolytic T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 82: 7394–7398, 1985a
Vega, M. A., Wallace, L., Rojo, S., Bragado, R., Aparicio, P., and López de Castro, J. A.: Delineation of functional sites in HLA-1327 antigens. Molecular analysis of HLA-1327 variant Wewak I defined by cytolytic T lymphocytes. J. Immunol. 135: 3323–3332, 1985b
Vega, M. A., Bragado, R., Iványi, P., Peláez, J. L., and López de Castro, J. A.: Molecular analysis of a functional subtype of HLA-1327. A possible evolutionary pathway for HLA-1327 polymorphism. J. Immunol. 137: 3557–3565, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Doménech, N., Ezquerra, A., Castaño, R. et al. Structural analysis of HLA-A2.4 functional variant KNE. Implications for the mapping of HLA-A2-specific T-cell epitopes. Immunogenetics 27, 196–202 (1988). https://doi.org/10.1007/BF00346586
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00346586